Literature DB >> 6301324

Interactions of plasma lipoproteins with endothelial cells.

T Henriksen, E M Mahoney, D Steinberg.   

Abstract

Mesh:

Substances:

Year:  1982        PMID: 6301324     DOI: 10.1111/j.1749-6632.1982.tb25711.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  17 in total

1.  Targeting oxidized LDL improves insulin sensitivity and immune cell function in obese Rhesus macaques.

Authors:  Shijie Li; Paul Kievit; Anna-Karin Robertson; Ganesh Kolumam; Xiumin Li; Karin von Wachenfeldt; Christine Valfridsson; Sherry Bullens; Ilhem Messaoudi; Lindsay Bader; Kyra J Cowan; Amrita Kamath; Nicholas van Bruggen; Stuart Bunting; Björn Frendéus; Kevin L Grove
Journal:  Mol Metab       Date:  2013-06-11       Impact factor: 7.422

2.  A role for endothelial cell lipoxygenase in the oxidative modification of low density lipoprotein.

Authors:  S Parthasarathy; E Wieland; D Steinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

3.  Essential role of phospholipase A2 activity in endothelial cell-induced modification of low density lipoprotein.

Authors:  S Parthasarathy; U P Steinbrecher; J Barnett; J L Witztum; D Steinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

4.  Cell surface expression of mouse macrosialin and human CD68 and their role as macrophage receptors for oxidized low density lipoprotein.

Authors:  M P Ramprasad; V Terpstra; N Kondratenko; O Quehenberger; D Steinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

5.  Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis.

Authors:  M T Quinn; S Parthasarathy; D Steinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

Review 6.  Probucol. A reappraisal of its pharmacological properties and therapeutic use in hypercholesterolaemia.

Authors:  M M Buckley; K L Goa; A H Price; R N Brogden
Journal:  Drugs       Date:  1989-06       Impact factor: 9.546

7.  Oxidized low-density lipoproteins impair endothelial function by inhibiting non-genomic action of thyroid hormone-mediated nitric oxide production in human endothelial cells.

Authors:  Roberto Vicinanza; Giuseppe Coppotelli; Carolina Malacrino; Tiziana Nardo; Barbara Buchetti; Luisa Lenti; Francesco S Celi; Susanna Scarpa
Journal:  Thyroid       Date:  2013-02       Impact factor: 6.568

8.  Endothelial cell-derived chemotactic activity for mouse peritoneal macrophages and the effects of modified forms of low density lipoprotein.

Authors:  M T Quinn; S Parthasarathy; D Steinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

9.  Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids.

Authors:  U P Steinbrecher; S Parthasarathy; D S Leake; J L Witztum; D Steinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

10.  Recognition of solubilized apoproteins from delipidated, oxidized low density lipoprotein (LDL) by the acetyl-LDL receptor.

Authors:  S Parthasarathy; L G Fong; D Otero; D Steinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1987-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.